AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

A Genetic Model for Deoxycytidine Kinase Deficiency

Technology Application
Develop new therapeutics for cancer and autoimmune disorders Identify and characterize agents that bind deoxycytidine kinase and/or modulate its activity Identify biological processes in which dCK plays a critical role Indentify small molecule dCK inhibitors
Detailed Technology Description
Researchers at UCLA have generated a novel deoxycytidine kinase (dCK) conditional knockout mouse to better understand the function of the deoxyribonucleoside salvage pathway and identify new therapeutic targets for immune disorders and cancer.
Others

State Of Development

The deoxycytidine kinase (dCK) conditional knockout mouse has been generated and validated.


Background

Production and maintenance of a balanced pool of deoxyribonucleoside triphosphates (dNTPs) for DNA synthesis is of critical importance for cell division.  Cellular dNTP pools are generated by two biosynthetic pathways: de novo synthesis and deoxyribonucleoside salvage.  Amongst salvage pathway enzymes, deoxycytidine kinase (dCK) has unique properties: it provides cells with all 4 dNTPs required for DNA synthesis (dATP, dCTP, dGTP, dTTP) and activates many pro-drugs that are widely used in cancer, autoimmunity and viral infections such as gemcitabine, fludarabine and cladribine.  dCK is highly expressed in hematopoietic/lymphoid cells and is also overexpressed in lymphoid malignancies and in some solid tumors.  These properties make dCK an attractive therapeutic and imaging target.


Related Materials

Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress. J Exp Med. (2012)
Requirement for deoxycytidine kinase in T and B lymphocyte development. Proc Natl Acad Sci U S A. (2010)


Tech ID/UC Case

22995/2010-015-0


Related Cases

2010-015-0

*Abstract
None
*Principal Investigator

Name: Wayne Austin

Department:


Name: Dean Campbell

Department:


Name: Johannes Czernin

Department:


Name: Hsiang I Liao

Department:


Name: Caius Radu

Department:


Name: Nagichettiar Satyamurthy

Department:


Name: Gerald Toy

Department:


Name: Owen Witte

Department:

Country/Region
USA

For more information, please click Here
Mobile Device